BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37228266)

  • 1. Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.
    Reumkens C; Endres A; Simons SO; Savelkoul PHM; Sprooten RTM; Franssen FME
    ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37228266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
    Cometa M; Ursitti A; Lombardo LP; Rana R; Gardani A; Contoli M; Papi A
    Respir Med; 2024 Feb; 222():107509. PubMed ID: 38145723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
    Crisafulli E; Sartori G; Huerta A; Gabarrús A; Fantin A; Soler N; Torres A
    Chest; 2023 Dec; 164(6):1422-1433. PubMed ID: 37516272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.
    Adir Y; Hakrush O; Shteinberg M; Schneer S; Agusti A
    ERJ Open Res; 2018 Jul; 4(3):. PubMed ID: 30083552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life burden of hospitalisations due to COPD exacerbations in Spain.
    Izquierdo JL; Rodríguez JM; Almonacid C; Benavent M; Arroyo-Espliguero R; Agustí A
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35983537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Rome Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbation: A Multicenter Cohort Study.
    Zeng J; Zhou C; Yi Q; Luo Y; Wei H; Ge H; Liu H; Zhang J; Li X; Pan P; Yi M; Cheng L; Liu L; Zhang J; Peng L; Pu J; Zhou H;
    Int J Chron Obstruct Pulmon Dis; 2024; 19():193-204. PubMed ID: 38249828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.
    Pomares X; Montón C; Huertas D; Marín A; Cuevas E; Casabella A; Martí S; Oliva JC; Santos S
    Respiration; 2021; 100(11):1070-1077. PubMed ID: 34365450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.
    Sprooten RTM; Rohde GGU; Lawyer G; Leijte WT; Wouters EFM; Franssen FME
    Respirology; 2019 Aug; 24(8):765-776. PubMed ID: 30897284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
    Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
    PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients.
    Waeijen-Smit K; Crutsen M; Keene S; Miravitlles M; Crisafulli E; Torres A; Mueller C; Schuetz P; Ringbæk TJ; Fabbian F; Mekov E; Harries TH; Lun CT; Ergan B; Esteban C; Quintana Lopez JM; López-Campos JL; Chang CL; Hancox RJ; Shafuddin E; Ellis H; Janson C; Suppli Ulrik C; Gudmundsson G; Epstein D; Dominguez J; Lacoma A; Osadnik C; Alia I; Spannella F; Karakurt Z; Mehravaran H; Utens C; de Kruif MD; Ko FWS; Trethewey SP; Turner AM; Bumbacea D; Murphy PB; Vermeersch K; Zilberman-Itskovich S; Steer J; Echevarria C; Bourke SC; Lane N; de Batlle J; Sprooten RTM; Russell R; Faverio P; Cross JL; Prins HJ; Spruit MA; Simons SO; Houben-Wilke S; Franssen FME
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38410700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease.
    Arostegui I; Legarreta MJ; Barrio I; Esteban C; Garcia-Gutierrez S; Aguirre U; Quintana JM;
    JMIR Med Inform; 2019 Apr; 7(2):e10773. PubMed ID: 30994471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study.
    Oliveira CC; Lee AL; McGinley J; Anderson GP; Clark RA; Thompson M; Clarke S; Baker T; Irving LB; Denehy L
    COPD; 2017 Oct; 14(5):518-525. PubMed ID: 28745525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a performance-based toolkit of the treatable traits of functioning in hospitalised patients with exacerbation of COPD: a survey-based study protocol.
    Leonardi NT; Kawakami DMO; Cruz J; Burtin C; Borghi-Silva A; Mendes RG
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38651092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment.
    Pomares X; Montón C; Bullich M; Cuevas O; Oliva JC; Gallego M; Monsó E
    Chest; 2018 May; 153(5):1125-1133. PubMed ID: 29427576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.
    Whittaker H; Rubino A; Müllerová H; Morris T; Varghese P; Xu Y; De Nigris E; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2022; 17():427-437. PubMed ID: 35264849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.
    Echevarria C; Steer J; Bourke SC
    COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?
    Pomares X; Montón C; Baré M; Pont M; Estirado C; Gea J; Quintana JM; Vidal S; Santiago A;
    COPD; 2016; 13(1):11-8. PubMed ID: 26417965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building toolkits for COPD exacerbations: lessons from the past and present.
    Sapey E; Bafadhel M; Bolton CE; Wilkinson T; Hurst JR; Quint JK
    Thorax; 2019 Sep; 74(9):898-905. PubMed ID: 31273049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting Borg score as a predictor of safe discharge of chronic obstructive pulmonary disease from the emergency department observation unit.
    Sengupta R; Loftus TM; Doers M; Jandarov RA; Phillips M; Ko J; Panos RJ; Zafar MA
    Acad Emerg Med; 2020 Dec; 27(12):1302-1311. PubMed ID: 32678934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.